Paul Little | Chief Financial Officer |
David-Alexandre Gros | Chief Executive Officer |
Steven Perrin | President and Chief Scientific Officer |
Pete Stavropoulos | Cantor Fitzgerald |
Thomas Smith | SVB Leerink Securities |
Matt Kaplan | Ladenburg Thalmann |
Rami Katkhuda | LifeSci Capital |
Greetings, and welcome to the Eledon Pharmaceuticals Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded today, March 30, 2023.
At this time, I would now like to turn the conference call over to Paul Little, Chief Financial Officer of Eledon.